Stay updated on Tagraxofusp in CD123+ AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2. The old revision line and the 'Back to Top' element were removed.
    Difference
    0.8%
    Check dated 2025-09-13T17:35:22.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-06T14:55:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    7%
    Check dated 2025-08-30T11:33:41.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:37:20.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:50:08.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:21:13.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.